David Kryza
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
-
- Prostate Cancer Treatment and Research 8
- Radiation Therapy and Dosimetry 4
-
- Radiopharmaceutical Chemistry and Applications 11
- Medical Imaging Techniques and Applications 4
- Co-authors
- M. Janier (17 shared papers)Claire Billotey (7 shared papers)Imen Miladi (5 shared papers)Jacqueline Taleb (9 shared papers)François Lux (9 shared papers)Pascal Perriat (5 shared papers)Stéphane Roux (4 shared papers)Olivier Tillement (9 shared papers)
- Journals
- EJNMMI Physics (4 papers)Bioconjugate Chemistry (3 papers)Nuclear Medicine and Biology (2 papers)Journal of Controlled Release (2 papers)Nanomedicine Nanotechnology Biology and Medicine (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
David Kryza
52 papers receiving 803 citations
Peers
Comparison fields: 5 of 84
- Biomaterials 171
- Radiology, Nuclear Medicine and Imaging 153
- Pulmonary and Respiratory Medicine 193
- Pharmaceutical Science 37
- Biomedical Engineering 201
Countries citing papers authored by David Kryza
This map shows the geographic impact of David Kryza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kryza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kryza more than expected).
Fields of papers citing papers by David Kryza
This network shows the impact of papers produced by David Kryza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kryza. The network helps show where David Kryza may publish in the future.
Co-authors
The 25 scholars most cited alongside David Kryza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 116 | |
| 2 | 2011 | 78 | |
| 3 | 2014 | 67 | |
| 4 | 2008 | 39 | |
| 5 | 2012 | 38 | |
| 6 | 2016 | 34 | |
| 7 | 2022 | 32 | |
| 8 | 2021 | 32 | |
| 9 | 2019 | 30 | |
| 10 | 2021 | 29 | |
| 11 | 2023 | 27 | |
| 12 | 2012 | 22 | |
| 13 | 2021 | 21 | |
| 14 | 2014 | 17 | |
| 15 | 2017 | 15 | |
| 16 | 2024 | 11 | |
| 17 | 2024 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 2023 | 10 | |
| 20 | 2009 | 10 |
About David Kryza
David Kryza is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology and Biomaterials, having authored 56 papers that have together received 811 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Prostate Cancer Treatment and Research (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (8 papers), RNA Interference and Gene Delivery (6 papers), Peptidase Inhibition and Analysis (4 papers), Radiation Therapy and Dosimetry (4 papers) and Medical Imaging Techniques and Applications (4 papers). The work is most often cited by research in Biomaterials (171 citations), Radiology, Nuclear Medicine and Imaging (153 citations), Pulmonary and Respiratory Medicine (193 citations), Pharmaceutical Science (37 citations) and Biomedical Engineering (201 citations). David Kryza has collaborated with scholars based in France, United States and Italy. Frequent co-authors include M. Janier, Claire Billotey, Imen Miladi, Jacqueline Taleb, François Lux, Pascal Perriat, Stéphane Roux, Olivier Tillement, Anne‐Laure Giraudet and Pauline Bonazza. Their work appears in journals such as EJNMMI Physics, Bioconjugate Chemistry, Nuclear Medicine and Biology, Journal of Controlled Release and Nanomedicine Nanotechnology Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.